Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Pheochromocytoma].

G Arnault-Ouary1, J F Chatal, B Charbonnel

  • 1Clinique d'endocrinologie Maladies métaboliques et nutrition, Hôtel-Dieu 44093 Nantes.

La Revue Du Praticien
|January 5, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy and adherence of glucagon-like peptide-1 receptor agonist treatment in patients with type 2 diabetes mellitus in real-life settings.

Diabetes & metabolism·2019
Same author

Glycaemic control and hypoglycaemia risk with insulin glargine 300 U/mL versus glargine 100 U/mL: A patient-level meta-analysis examining older and younger adults with type 2 diabetes.

Diabetes & metabolism·2018
Same author

After the LEADER trial and SUSTAIN-6, how do we explain the cardiovascular benefits of some GLP-1 receptor agonists?

Diabetes & metabolism·2017
Same author

Predicting severe hypoglycaemia with self-monitoring of blood glucose in type 1 diabetes.

Diabetes & metabolism·2017
Same author

Short-term effect of severe hypoglycaemia on glycaemic control in the Diabetes Control and Complications Trial.

Diabetes & metabolism·2016
Same author

Which oral antidiabetic drug to combine with metformin to minimize the risk of hypoglycemia when initiating basal insulin?: A randomized controlled trial of a DPP4 inhibitor versus insulin secretagogues.

Diabetes research and clinical practice·2016
Same journal

[Prolonged fever].

La Revue du praticien·2026
Same journal

[Lower gastrointestinal bleeding].

La Revue du praticien·2026
Same journal

[Management of antiplatelet agents and oral anticoagulants in cases of gastrointestinal bleeding].

La Revue du praticien·2026
Same journal

[A history of child abuse intervention in the West].

La Revue du praticien·2026
Same journal

[Agranulocytose médicamenteuse].

La Revue du praticien·2026
Same journal

[Patient education in heart failure].

La Revue du praticien·2026
See all related articles

Pheochromocytoma, a catecholamine-secreting tumor, often presents as sporadic adrenal tumors. Diagnosis involves measuring urinary metanephrines or plasma methoxyamines, with surgical treatment following medical management.

Area of Science:

  • Endocrinology
  • Oncology
  • Medical Diagnostics

Background:

  • Pheochromocytoma is an adrenal tumor secreting catecholamines.
  • While often sporadic and benign, it can be extra-adrenal, malignant, or familial.

Purpose of the Study:

  • To summarize the key aspects of pheochromocytoma diagnosis and management.
  • To highlight diagnostic methods and treatment strategies for this rare tumor.

Main Methods:

  • Review of clinical presentations, including hypertension and paroxysmal symptoms.
  • Biological diagnosis via urinary catecholamine, metanephrine, or plasma methoxyamine measurement.
  • Tumor localization using CT, NMR imaging, and MIBG scintigraphy.

Main Results:

Related Experiment Videos

  • Pheochromocytoma can manifest with diverse clinical symptoms beyond typical hypertension.
  • Measurement of urinary metanephrines or plasma methoxyamines offers high sensitivity and specificity.
  • Imaging techniques like CT, NMR, and MIBG scintigraphy are effective for tumor localization.

Conclusions:

  • Early and accurate diagnosis of pheochromocytoma is crucial.
  • A combination of clinical, biological, and imaging methods ensures effective management.
  • Surgical resection following medical preparation is the standard treatment approach.